Daniil Gataulin
Stock Analyst at Chardan Capital
(4.17)
# 1,569
Out of 4,978 analysts
72
Total ratings
41.8%
Success rate
16.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $21 → $23 | $9.87 | +133.03% | 3 | Jun 25, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $11 → $13 | $5.41 | +140.30% | 3 | Jun 17, 2026 | |
| CRVO CervoMed | Reiterated: Buy | $21 | $2.44 | +760.66% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $12.76 | +174.29% | 2 | May 14, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $9.91 | +434.81% | 3 | May 12, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $32.77 | +86.15% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $1.02 | +292.16% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $0.9984 | +601.12% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $4.61 | +138.61% | 4 | May 7, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $29 | $3.45 | +740.58% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $42.49 | -12.92% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.98 | +551.63% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $0.6769 | +47.73% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.93 | +307.12% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $3.18 | +497.48% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.111 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.83 | n/a | 2 | Feb 15, 2023 |
Ocular Therapeutix
Jun 25, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $9.87
Upside: +133.03%
Opus Genetics
Jun 17, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $5.41
Upside: +140.30%
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $2.44
Upside: +760.66%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $12.76
Upside: +174.29%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $9.91
Upside: +434.81%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $32.77
Upside: +86.15%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $1.02
Upside: +292.16%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $0.9984
Upside: +601.12%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $4.61
Upside: +138.61%
EyePoint
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $3.45
Upside: +740.58%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $42.49
Upside: -12.92%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $7.98
Upside: +551.63%
Jan 2, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $0.6769
Upside: +47.73%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $3.93
Upside: +307.12%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $3.18
Upside: +497.48%
Jun 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.111
Upside: n/a
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $13.83
Upside: n/a